Cogent Biosciences, Inc. (COGT) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $223.46M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $223.17M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $222.90M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-09-30: Long-term Debt, Excluding Current MaturitiesUSD $44.25M; Long-term DebtUSD $44.25M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $0.00.
Cogent Biosciences, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Long-term Debt, Fair Value USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $223.46M | (m) | (m) | (m) | (m) | (m) | $230.00M | $281.30M | $6.54M |
| 2026-03-31 | (m) | $223.17M | (m) | (m) | (m) | (m) | (m) | $230.00M | $281.00M | $6.83M |
| 2025-12-31 | (m) | $222.90M | (m) | (m) | (m) | (m) | (m) | $230.00M | $270.30M | $7.11M |
| 2025-09-30 | $44.25M | $44.25M | $0.00 | $0.00 | $0.00 | $14.58M | $0.00 | $50.00M | (m) | $5.75M |
| 2025-06-30 | $43.95M | $43.95M | $0.00 | $0.00 | $0.00 | $14.58M | $0.00 | $50.00M | (m) | $6.05M |
| 2024-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |